4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001415889-24-025746
Director sold 15,000 shares at an average $48.03 ($720,493)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SEIDENBERG BETH C Director | 2024-10-28 | Sale 10b5-1 | −14,798 | $48.01 | $710,486 | 131,755 | D |
| SEIDENBERG BETH C Director | 2024-10-28 | Sale 10b5-1 | −202 | $49.54 | $10,007 | 131,553 | D |
| Open-market sales · 15,000 sh · avg $48.03 · $720,493 | |||||||
Loading xslF345X05/form4-10302024_081020.xml…